FDA Orange Book
Generic for Viread
Viread contains tenofovir disoproxil. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Viread is tenofovir disoproxil. 11 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 4 of the 5 Viread products the Orange Book lists.
Run it in Rivvi
Map Viread and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Viread products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| powder, oral | 40MG/SCOOPFUL | Marketed (Rx) | None | 0 | None |
| tablet, oral | 150MG | Marketed (Rx) | AB | 2 | AB |
| tablet, oral | 200MG | Marketed (Rx) | AB | 3 | AB |
| tablet, oral | 250MG | Marketed (Rx) | AB | 3 | AB |
| tablet, oral | 300MG | Marketed (Rx) | AB | 11 | AB |
NDA 022577, 021356, held by GILEAD SCIENCES INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic tenofovir disoproxil
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| AUROBINDO PHARMA LTD | 090647 | AB (A-rated, therapeutically equivalent) | January 26, 2018 | 150MG, 200MG, 250MG, 300MG |
| TEVA PHARMACEUTICALS USA | 091612 | AB (A-rated, therapeutically equivalent) | January 26, 2018 | 150MG, 200MG, 250MG, 300MG |
| CIPLA LTD | 078800 | AB (A-rated, therapeutically equivalent) | January 26, 2018 | 300MG |
| HETERO LABS LTD UNIT III | 090636 | AB (A-rated, therapeutically equivalent) | January 26, 2018 | 300MG |
| MACLEODS PHARMACEUTICALS LTD | 203232 | AB (A-rated, therapeutically equivalent) | January 26, 2018 | 300MG |
| STRIDES PHARMA GLOBAL PTE LTD | 090742 | AB (A-rated, therapeutically equivalent) | January 26, 2018 | 300MG |
| QILU PHARMACEUTICAL CO LTD | 209498 | AB (A-rated, therapeutically equivalent) | March 2, 2018 | 200MG, 250MG, 300MG |
| CHARTWELL LIFE MOLECULES LLC | 206481 | AB (A-rated, therapeutically equivalent) | July 26, 2018 | 300MG |
| REYOUNG CORPORATION | 211337 | AB (A-rated, therapeutically equivalent) | March 2, 2023 | 300MG |
| PHARMOBEDIENT CONSULTING LLC | 079071 | AB (A-rated, therapeutically equivalent) | February 29, 2024 | 300MG |
| MICRO LABS LTD | 206157 | AB (A-rated, therapeutically equivalent) | December 18, 2025 | 300MG |
Viread NDC codes
Questions
Is there a generic for Viread?
Yes. The generic name for Viread is tenofovir disoproxil. 11 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 4 of the 5 Viread products the Orange Book lists.
What is the generic name for Viread?
The active ingredient in Viread is tenofovir disoproxil, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Viread and Tenofovir Disoproxil
- What is Tenofovir Disoproxil used for?FDA label uses
- Is Tenofovir Disoproxil a controlled substance?Federal schedule
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- NDC 61958-0401Viread NDC record
- NDC 61958-0403Viread NDC record
- NDC 61958-0404Viread NDC record